1. DDIS-12. ONC201: THE FIRST SELECTIVE, NON-COMPETITIVE DRD2/3 ANTAGONIST FOR CLINICAL NEURO-ONCOLOGY. (5th November 2018) Authors: Vijay Prabhu, Varun; Madhukar, Neel; Anantharaman, Lakshmi; Sulli, Chidananda; Davidson, Edgar; Deacon, Sean; Tarapore, Rohinton; Rucker, Joseph; Charter, Neil; Doranz, Benjamin; Oster, Wolfgang; Stogniew, Martin; Elemento, Olivier; Free, R Benjamin; Sibley, David; Allen, Joshua Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXTH-33. RECEPTOR PHARMACOLOGY OF ONC201: THE FIRST BITOPIC DRD2 ANTAGONIST FOR CLINICAL NEURO-ONCOLOGY. (11th November 2019) Authors: Benjamin Free, R; Cuoco, Caroline; Prabhu, Varun; Willette, Blair; Day, Marilyn; Anantharaman, Lakshmi; Sulli, Chidananda; Davidson, Edgar; Deacon, Sean; Rucker, Joseph; Charter, Neil; Doranz, Benjamin; Oster, Wolfgang; Stogniew, Martin; Robert Lane, J; Sibley, David; Allen, Joshua Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗